Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-02-13

FDA Approved: ELETRIPTAN HYDROBROMIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Eletriptan Hydrobromide from Teva Pharmaceuticals USA, Inc. This action updates the approved Eletriptan Hydrobro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eletriptan Hydrobromide (eletriptan hydrobromide)

Snippet

SUPPL AP for ELETRIPTAN HYDROBROMIDE (ELETRIPTAN HYDROBROMIDE)